Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity

v3.21.2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Shares
Additional paid in capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Balance (in shares) at Dec. 31, 2019   111,798,000      
Balance at Dec. 31, 2019 $ 298,600 $ 746,487 $ 25,394 $ (805) $ (472,476)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options (in shares)   1,318,000      
Shares issued on exercise of stock options 5,400 $ 8,254 (2,854)    
Issuance of common shares (in shares)   13,333,000      
Issue of common shares 200,000 $ 200,000      
Share issue costs (12,268) $ (12,268)      
Exercise of warrants (in shares)   1,000      
Exercise of warrants 1 $ 2 (1)    
Share-based compensation 12,309   12,309    
Net loss (94,606)       (94,606)
Balance (in shares) at Sep. 30, 2020   126,450,000      
Balance at Sep. 30, 2020 409,436 $ 942,475 34,848 (805) (567,082)
Balance (in shares) at Jun. 30, 2020   112,705,000      
Balance at Jun. 30, 2020 257,698 $ 752,357 31,098 (805) (524,952)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options (in shares)   412,000      
Shares issued on exercise of stock options 1,525 $ 2,386 (861)    
Issuance of common shares (in shares)   13,333,000      
Issue of common shares 200,000 $ 200,000      
Share issue costs (12,268) $ (12,268)      
Share-based compensation 4,611   4,611    
Net loss (42,130)        
Balance (in shares) at Sep. 30, 2020   126,450,000      
Balance at Sep. 30, 2020 $ 409,436 $ 942,475 34,848 (805) (567,082)
Balance (in shares) at Dec. 31, 2020 126,725,000 126,725,000      
Balance at Dec. 31, 2020 $ 407,750 $ 944,328 39,383 (805) (575,156)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options (in shares)   2,324,000      
Shares issued on exercise of stock options 15,352 $ 22,097 (6,745)    
Exercise of warrants (in shares)   521,000      
Exercise of warrants 37 $ 734 (697)    
Share-based compensation 22,666   22,666    
Other comprehensive income 11     11  
Net loss $ (147,644)       (147,644)
Balance (in shares) at Sep. 30, 2021 129,570,000 129,570,000      
Balance at Sep. 30, 2021 $ 298,172 $ 967,159 54,607 (794) (722,800)
Balance (in shares) at Jun. 30, 2021   128,396,000      
Balance at Jun. 30, 2021 332,257 $ 954,572 51,022 (792) (672,545)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options (in shares)   1,172,000      
Shares issued on exercise of stock options 9,074 $ 12,579 (3,505)    
Exercise of warrants (in shares)   2,000      
Exercise of warrants 6 $ 8 (2)    
Share-based compensation 7,092   7,092    
Other comprehensive income (2)     (2)  
Net loss $ (50,255)        
Balance (in shares) at Sep. 30, 2021 129,570,000 129,570,000      
Balance at Sep. 30, 2021 $ 298,172 $ 967,159 $ 54,607 $ (794) $ (722,800)